Français
ItalianoBond Advanz Pharma Corp 7% ( USC26215AA88 ) in USD
| Issuer | Advanz Pharma Corp | ||||||
| Market price | 6.75 % ⇌ | ||||||
| Country |  Canada
|
||||||
| ISIN code |
 USC26215AA88 ( in USD )
|
||||||
| Interest rate | 7% per year ( payment 2 times a year) | ||||||
| Maturity | 14/04/2023 - Bond has expired | ||||||
|
Prospectus brochure in PDF format |
|||||||
| Minimal amount | 2 000 USD | ||||||
| Total amount | 735 000 000 USD | ||||||
| Cusip | C26215AA8 | ||||||
| Standard & Poor's ( S&P ) rating | N/A | ||||||
| Moody's rating | N/A | ||||||
| Detailed description |
Advanz Pharma Corp is a specialty pharmaceutical company focused on acquiring, developing, and commercializing branded and generic prescription drugs, primarily in the areas of central nervous system, pain management, and gastroenterology. The Bond issued by Advanz Pharma Corp ( Canada ) , in USD, with the ISIN code USC26215AA88, pays a coupon of 7% per year. The coupons are paid 2 times per year and the Bond maturity is 14/04/2023 |
||||||
| |||||||